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Glutathione S-transferase class mu regulation of apoptosis signal-
regulating kinase 1 protein during VCD-induced ovotoxicity in neonatal
rat ovaries
Abstract
4-vinylcyclohexene diepoxide (VCD) destroys ovarian primordial and small primary follicles via apoptosis. In
mice, VCD exposure induces ovarian mRNA expression of glutathione S-transferase (GST) family members,
including isoform mu (Gstm). Extra-ovarian GSTM negatively regulates pro-apoptotic apoptosis signal-
related kinase 1 (ASK1) through protein complex formation, which dissociates during stress, thereby
initiating ASK1-induced apoptosis. The present study investigated the ovarian response of Gstm mRNA and
protein to VCD. Induction of Ask1 mRNA at VCD-induced follicle loss onset was determined. Ovarian
GSTM:ASK1 protein complex formation was investigated and VCD exposure effects thereon evaluated.
Phosphatidylinositol-3 kinase (PI3K) regulation of GSTM protein was also studied. Postnatal day (PND) 4
rat ovaries were cultured in control media ±: 1) VCD (30 μM) for 2–8d; 2) VCD (30 μM) for 2d, followed by
incubation in control media for 4d (acute VCD exposure); or 3) LY294002 (20 μM) for 6d. VCD exposure
did not alter Gstm mRNA expression, however, GSTM protein increased (P < 0.05) after 6d of both the acute
and chronic treatments. Ask1 mRNA increased (0.33-fold; P < 0.05) relative to control after 6d of VCD
exposure. Ovarian GSTM:ASK1 protein complex formation was confirmed and, relative to control, the
amount of GSTM bound to ASK1 increased 33% (P < 0.05) by chronic but with no effect of acute VCD
exposure. PI3K inhibition increased (P < 0.05) GSTM protein by 40% and 71% on d4 and d6, respectively.
These findings support involvement of GSTM in the ovarian response to VCD exposure, through regulation
of pro-apoptotic ASK1.
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Abstract
4-vinylcyclohexene diepoxide (VCD) destroys ovarian primordial and small primary follicles via
apoptosis. In mice, VCD exposure induces ovarian mRNA expression of glutathione S-transferase
(GST) family members, including isoform mu (Gstm). Extra-ovarian GSTM negatively regulates
pro-apoptotic apoptosis signal-related kinase 1 (ASK1) through protein complex formation, which
dissociates during stress, thereby initiating ASK1-induced apoptosis. The present study
investigated the ovarian response of Gstm mRNA and protein to VCD. Induction of Ask1 mRNA
at VCD-induced follicle loss onset was determined. Ovarian GSTM:ASK1 protein complex
formation was investigated and VCD exposure effects thereon evaluated. Phosphatidylinositol-3
kinase (PI3K) regulation of GSTM protein was also studied. Postnatal day (PND) 4 rat ovaries
were cultured in control media ±: 1) VCD (30 μM) for 2–8d; 2) VCD (30 μM) for 2d, followed by
incubation in control media for 4d (acute VCD exposure); or 3) LY294002 (20 μM) for 6d. VCD
exposure did not alter Gstm mRNA expression, however, GSTM protein increased (P < 0.05) after
6d of both the acute and chronic treatments. Ask1 mRNA increased (0.33-fold; P < 0.05) relative
to control after 6d of VCD exposure. Ovarian GSTM:ASK1 protein complex formation was
confirmed and, relative to control, the amount of GSTM bound to ASK1 increased 33% (P < 0.05)
by chronic but with no effect of acute VCD exposure. PI3K inhibition increased (P < 0.05) GSTM
protein by 40% and 71% on d4 and d6, respectively. These findings support involvement of
GSTM in the ovarian response to VCD exposure, through regulation of pro-apoptotic ASK1.
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The ovary is the female gonad composed of oocyte-containing follicles at various stages of
development. Females are born with a finite number of the most immature follicular stage,
termed primordial follicles, which, once destroyed, cannot be regenerated (Hirshfield, 1991).
Exposure to environmental factors that cause follicular damage and depletion can impair
fertility and induce ovarian failure (menopause; Mattison et al., 1980). An occupational
chemical known to selectively destroy primordial and small primary follicles in the ovaries
of mice and rats is 4-vinylcyclohexene diepoxide (VCD, Kao et al., 1999; Smith et al.,
1990). VCD is the active metabolite of 4-vinylcyclohexene (VCH), an industrial diluent for
epoxides (IARC, 1976). Repeated daily dosing of rats with VCD (80 mg/kg/day,
intraperitoneal) for 15 days results in approximately 50% depletion of primordial and small
primary follicles relative to controls, with no significant effect on larger follicles or corpora
lutea (Smith et al., 1990; Flaws et al., 1994; Springer et al., 1996a,b). VCD-induced
primordial and small primary follicle loss begins on day 6 of in vitro exposure in postnatal
day (PND) 4 cultured Fisher 344 (F344) rat ovaries (Keating et al., 2009). Mechanistic
studies have revealed that VCD induces follicle loss by accelerating the natural process of
atresia (apoptosis) in both a time- and dose-dependent manner (Springer et al., 1996a; Hu et
al., 2001a; Devine et al., 2002).
VCH may be metabolized (bioactivated) in the ovary to VCD by the action of the
cytochrome P450 (CYP) family member CYP 2E1 (Cannady et al., 2003; Rajapaksa et al.,
2007). Cyp 2e1-null mice had less follicle loss compared to their wild type control
littermates (Rajapaksa et al., 2007), suggesting the involvement of CYP 2E1 in VCH
bioactivation. Conversely, VCD can be detoxified in the ovary to a less ovotoxic tetrol
metabolite through the action of microsomal epoxide hydrolase (mEH) (Flaws et al., 1994;
Cannady et al., 2002; Keating et al., 2008; Bhattacharya et al., 2012). Studies have shown
that VCD induces mEH mRNA and protein expression both in vivo and in vitro prior to an
observed follicle loss in mice and rats (Cannady et al., 2002; Keating et al., 2008;
Bhattacharya et al., 2012). Additionally when mEH is inhibited in vitro using cyclohexene
oxide (CHO) in the presence of VCD, more follicle loss results relative to those ovaries
treated only with VCD, thereby supporting an ovarian detoxification role for mEH during
VCD exposure (Bhattacharya et al., 2012).
Glutathione (GSH) is a ubiquitous antioxidant that protects cells against oxidative stress and
electrophilic compounds (DeLeve and Kaplowitz, 1991). GSH functions in two major ways:
1) through conjugation to electrophilic compounds resulting in their more rapid excretion
from the body; or 2) directly reducing and neutralizing reactive oxygen intermediates in a
coupled reaction involving GSH peroxidase (DeLeve and Kaplowitz, 1991). The glutathione
S-transferase (GST) enzyme family catalyze conjugation of GSH to xenobiotics (Jakoby et
al., 1978), and the ovary is capable of synthesizing GSH (Luderer et al., 2001). The mRNA
encoding the GST isoforms pi (Gstp) and mu (Gstm) are increased in response to VCD
exposure in cultured PND4 mouse ovaries (Keating et al., 2008). Additionally, VCD
increases Gstp mRNA and protein in cultured PND4 rat ovaries prior to (d4) and at times of
(d6, d8) VCD-induced follicle loss (Keating et al., 2010). These observations support that
the GST isoforms mu and pi are involved in the ovarian response to VCD exposure, and
may potentially catalyze VCD:GSH conjugation.
In addition to GSH conjugation, GST enzymes are involved in cell signaling pathway
regulation (Cho et al., 2001; Dorion et al., 2002; Keating et al., 2010). GSTP forms a protein
complex with c-JUN N-terminal kinase (JNK; Adler et al., 1999) and is likely to negatively
regulate its action in the rat ovary (Keating et al., 2010). The amount of JNK protein bound
to GSTP increased after 6 days of VCD exposure (Keating et al., 2010) with a concomitant
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decrease in unbound JNK and phosphorylated c-JUN (p-c-JUN) protein levels. Furthermore,
a decrease in p-c-JUN preceded the increase in JNK bound to GSTP, indicating that JNK
activity was impaired through the GSTP interaction (Keating et al., 2010).
Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase
kinase (MAPKKK) which is capable of activating the pro-apoptotic JNK and p38 MAPK
signaling pathways (Ichijo et al., 1997). In extra-ovarian tissues, GSTM physically interacts
with ASK1 and functions to repress ASK1-mediated apoptosis (Cho et al., 2001). The
GSTM:ASK1 protein complex dissociates in response to stress and thereby triggers
activation of apoptosis by ASK1 (Dorion et al., 2002). It is therefore known that GSTM
modulates stress-activity signals by suppressing ASK1. Interestingly, VCD-induced
apoptosis involves the action of JNK and p-c-JUN (Hu et al., 2002). Thus, ovarian GSTM is
potentially involved in the ovarian response to VCD exposure.
Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase involved in various cellular functions
including cell growth and survival, proliferation, and differentiation (Vivanco and Sawyers,
2007). In the ovary, the PI3K signaling pathway plays an important role in primordial
follicles by maintaining oocyte viability and directing their recruitment into the growing
follicular pool (Castrillon et al., 2003; Reddy et al., 2005; Liu et al., 2006). Impairment of
PI3K signaling occurs during VCD-induced ovotoxicity (Keating et al., 2011), while PI3K
inhibition prevented VCD-induced primordial follicle loss in cultured PND4 rat ovaries
(Keating et al., 2009). Recently, it has been shown that the xenobiotic biotransformation
enzymes mEH and Gstp are regulated by PI3K signaling in cultured PND4 rat ovaries and
Gstm mRNA was increased by PI3K inhibition (Bhattacharya et al., 2012; Bhattacharya and
Keating, 2012). Taken together, these findings also point to regulation of Gstm by PI3K
signaling.
To determine if GSTM is associated with the ovarian response to VCD as well as in
regulation of pro-apoptotic ASK1, several approaches were taken: the first was to study the
temporal pattern of Gstm mRNA and protein expression in response to VCD. The second
was to determine any effect of VCD on Ask1 mRNA expression at the time of the onset of
VCD-induced follicle loss. The third approach was to establish the presence of a
GSTM:ASK1 protein complex in the rat ovary and to study the effect of VCD exposure
(both acute and chronic) upon this complex. Finally, because Gstm mRNA expression is
increased in cultured PND4 rat ovaries during inhibition of the PI3K pathway (Bhattacharya
and Keating, 2012) regulation of GSTM by PI3K was evaluated.
Materials and Methods
Reagents
4-vinylcyclohexene diepoxide (VCD, mixture of isomers, >99% purity), ascorbic acid,
transferrin, bovine serum albumin (BSA), 2-β-mercaptoethanol, 30% acrylamide/0.8% bis-
acrylamide, ammonium persulphate, glycerol, N′N′N′N′-Tetramethyl-ethylenediamine
(TEMED), Tris base, Tris HCL, sodium chloride, Tween-20 were purchased from Sigma-
Aldrich Inc. (St Louis, MO). Dulbecco’s Modified Eagle Medium: nutrient mixture F-12
(Ham) 1x (DMEM/Ham’s F12), Albumax, penicillin (5000U/ml), Hanks’ Balanced Salt
Solution (without CaCl2, MgCl2 or MgSO4), Gstm and β-actin primers, and superscript III
one-step RT-PCR system were obtained from Invitrogen Co. (Carlsbad, CA). Gapdh and
Ask1 primers were obtained from the DNA facility of the Office of Biotechnology at Iowa
State University. Millicell-CM filter inserts and anti-GSTM antibodies were purchased from
Millipore (Bedford, MA). The anti-ASK1 primary antibody was obtained from Cell
Signaling Technology (Danvers, MA). 48-well cell culture plates were purchased from
Corning Inc. (Corning, NY). RNeasy Mini kit, QIA shredder kit, RNeasy Mini Elute kit, and
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Quantitect™ SYBR Green PCR kit were purchased from Qiagen Inc. (Valencia, CA).
RNAlater was obtained from Ambion Inc. (Austin, TX). 2-(4-morpholinyl)-8-phenyl-4H-1-
benzopyran-4-one (LY294002; CAS#154447-36-6) was purchased from A.G. Scientific,
Inc. (San Diego, CA). Pierce BCA protein Assay Kit was purchased from Thermo Scientific
(Rockford, IL). The goat anti-rabbit secondary antibody was obtained from Thermo
Scientific, (Lafayette, CO). Ponceau S was from Fisher Scientific (Asheville, NC). ECL plus
chemical luminescence detection kit was obtained from GE Healthcare, Amersham
(Buckinghamshire, UK).
Animals
Rats were housed two per cage in plastic cages and maintained in a controlled environment
(22 ± 2°C; 12h light/12h dark cycles). The animals were provided a standard diet with ad
libitum access to food and water, and allowed to give birth. All animal experimental
procedures were approved by the Iowa State University’s Institutional Animal Care and Use
Committee.
In vitro ovarian cultures
Ovaries from PND4 Fisher 344 (F344) rats were cultured as described by Parrott and
Skinner (1999). Briefly, pups were euthanized by CO2 inhalation followed by decapitation.
Ovaries were removed, trimmed of oviduct and other excess tissue and placed onto
Millicell-CM membrane floating on 250 μl of DMEM/Ham’s F12 medium containing 1 mg/
ml BSA, 1 mg/ml Albumax, 50 μg/ml ascorbic acid, 5 U/ml penicillin and 27.5 μg/ml
transferrin per well in a 48 well plate previously equilibrated to 37°C. One ovary was placed
in the control treatment, while the contralateral ovary was exposed to the experimental
treatment. A drop of medium was placed on top of each ovary to prevent it from drying.
Ovaries were treated with vehicle control medium (1% DMSO), VCD (30 μM) or
LY294002 (20 μM) and maintained at 37°C and 5% CO2 for 2–8 d. For chronic VCD
exposure, ovaries were continuously exposed to VCD (30 μM) on alternate days and
samples were collected accordingly. For the acute VCD exposure, ovaries were exposed for
2d to VCD (30 μM) beginning at the onset of culture and were subsequently incubated in
control medium for a further 4d for a total of 6d of culture. The concentration (30 μM) of in
vitro VCD exposure was previously determined to cause about 50% loss of both primordial
and small primary follicles after 6d (Devine et al., 2002; Keating et al., 2009). The
concentration of LY294002 (20 μM) was previously shown to be effective in the rat PND4
ovary culture system (Keating et al., 2009). For cultures lasting for more than 2d, media was
changed every alternate day and treatment added.
RNA isolation and polymerase chain reaction (PCR)
Following 2, 4, 6 or 8 d of in vitro culture, ovaries treated with control or VCD (30 μM)
were stored in RNAlater at −80°C. Total RNA was isolated from ovaries (n=3; 10 ovaries
per pool) using an RNeasy Mini kit (Qiagen) following the manufacturer’s instructions.
RNA was eluted in 14ul of RNase-free water and the concentration was determined using a
NanoDrop (λ=260/280 nm; ND 1000; Nanodrop Technologies Inc, Wilmington, DE). Total
RNA (500 ng) was reverse transcribed to cDNA using Superscript III One-Step RT-PCR
System (Invitrogen). Gstm and β-actin (Actb) were amplified on a Rotor-Gene 3000
(Corbett Research, Sydney, Australia). An Eppendorf mastercycler (Hauppauge, NY) was
used to amplify Gapdh and Ask1. A Quantitect™ SYBR Green PCR kit (Qiagen
Inc.Valencia, CA) was used for amplification. The primers used for Gstm and Actb were
those described in (Keating et al., 2008). The Gapdh primers were from Bhattacharya and
Keating (2012). Ask1 primers were: forward - 5′-
AGAAAAGGACCAAGAAATTAAGCAC-3′; reverse-5′-
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AACCGACTTATAGTGTCTTCGTCAG-3′. There was no difference in Actb or Gapdh
mRNA expression level between vehicle control and VCD treated ovaries.
Protein Isolation
Pools (n = 3 pools; 10 ovaries per pool for Western blotting; 20 ovaries per pool for
immunoprecipitation) of whole ovarian protein suspensions were obtained by
homogenization in tissue lysis buffer containing protease and phosphatase inhibitors
(Thompson et al., 2005). SDS-free lysis buffer was used to isolate protein for
immunoprecipitation. After homogenization, samples were placed on ice for 30 min,
followed by two rounds of centrifugation at 10,000 rpm for 15 min. Protein quantification
was performed using a standard BCA protocol on a 96-well assay plate. Emission
absorbance was detected with a λ= 540nm excitation on a Synergy™ HT Multi-Detection 1
Microplate Reader using KC4™ software (Bio-Tek® Instruments Inc., Winooski, VT).
Protein concentrations were calculated from a BSA protein standard curve.
Protein immunoprecipitation
Protein immunoprecipitation was performed as previously described (Bhattacharya and
Keating, 2012). Briefly, ovarian protein (30 μg) was incubated overnight at 4°C with 15 μl
of anti-ASK1 antibody. Protein G agarose beads were washed, added to the protein-antibody
mixture and incubated at 4°C for 3 h with shaking, followed by centrifugation at 10,000 rpm
for 10 mins. The supernatant containing the unbound protein was saved for Western
blotting. After washing with lysis buffer beads were incubated with Laemmli sample buffer
(40 μl) at 95°C for 10 min. Thereafter, the beads were centrifuged and the bound protein
(supernatant) fraction (40 μl) was collected.
Western blot analysis
10% SDS-PAGE gels were used to separate proteins (n=3; 10 μg total protein or 20 μl
unbound or bound immunoprecipitation fractions) followed by transfer onto nitrocellulose
membranes as previously described (Thompson et al., 2005). Membranes were blocked for 1
h with shaking at 4°C in 5% milk in Tris-buffered saline with Tween-20 (TTBS). Primary
antibody diluted in 5% milk in TTBS was added to the membranes and incubated overnight
at 4°C with rocking. The GSTM and ASK1 antibody dilutions used were 1:200 and 1:1000.
Membranes were washed three times (10 min) in TTBS and incubated in appropriate HRP-
conjugated secondary antibody (1:2000) for 1hr at room temperature. Membranes were
washed three times (10 min) in TTBS followed by a single wash for 10 min in Tris Buffered
Saline (TBS). Membranes were incubated in ECL plus chemiluminescence detection
substrate for 5 min and exposed to X-ray film. Equal total protein loading was confirmed by
Ponceau S staining of membranes. Densitometry of the appropriate bands was quantified
using ImageJ software (NCBI). Each band was normalized to an appropriate internal control
– Ponceau S for total protein measurements and to ASK1 for immunoprecipitation. The
treatment values were compared to control values using Prism 5.04 software to determine
any difference between experimental treatments.
Statistical analysis
All statistical analyses were performed using Prism 5.04 software (GraphPad Software). One
ovary from each animal was placed in control media while the contralateral ovary was
placed in the experimental treatment, thus data were analyzed by paired t-tests comparing
the treated ovaries to controls. Statistical significance was defined as P < 0.05. For Western
blotting, statistical analysis was performed on the raw data comparing experimental
treatment to the respective control at each time-point. For each experiment, the n-value
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equals three groups that consisted of 8–10 ovaries per group, and data are presented as mean
value +/− standard error.
Results
Temporal effect of chronic VCD exposure on Gstm mRNA expression in PND4 F344 rat
ovaries
To investigate the effect of VCD on ovarian Gstm mRNA, real-time PCR was performed
over the time-course of VCD exposure; 2d, 4d, 6d or 8d. Relative to control ovaries, no
change in Gstm mRNA expression was observed at any time point (Figure 1).
Temporal effect of chronic VCD exposure on GSTM protein in F344 rat ovaries
To determine any impact of VCD exposure on GSTM protein level, PND4 rat ovaries were
cultured in control media or media containing VCD (30 μM) for 4d, 6d or 8d. There was no
effect of VCD on GSTM protein level on d4. Relative to control-treated ovaries, VCD
increased (P < 0.05) GSTM protein level on d6 by 13% and on d8 by 9% (Figure 2A, B).
Induction of Ask1 mRNA in F344 rat ovaries by VCD at the time of follicle loss onset
To study if VCD induces Ask1 mRNA, PND4 rat ovaries were cultured in control media or
media containing VCD (30 μM) for 6 d. Ask1 expression was measured on d6 since this
time point coincides with the beginning of VCD-induced follicle loss. Relative to control-
treated ovaries, Ask1 mRNA was increased (0.33-fold; P < 0.05) by VCD exposure (Figure
3).
Effect of chronic VCD exposure on GSTM:ASK1 protein complex formation in F344 rat
ovaries
To evaluate the presence of a GSTM:ASK1 protein complex in the ovary as well as to
investigate the effect of VCD exposure on this complex during VCD exposure, PND4 F344
rat ovaries were collected at the time points prior to (d4) and at the time of (d6) VCD-
induced follicle loss. A GSTM:ASK1 protein complex was detected in ovarian tissue
(Figure 4A). There was no effect of VCD on the amount of GSTM bound to ASK1 on d4
but this was increased by 33% (P < 0.05) on d6 (Figure 4B). There was no impact of VCD
exposure or ASK1 interaction on GSTM protein that was unbound to ASK1 at either time
point (Figure 4C, D).
Acute VCD exposure effects on GSTM protein level in F344 rat ovaries
Whether a single (acute) exposure of PND4 rat ovaries for 2d to VCD was sufficient to
induced increased GSTM protein levels was determined. Protein was collected 6d after the
onset of culture. Relative to control-treated ovaries, GSTM protein was increased (P < 0.05)
on d6 by 6% (Figure 5A, B).
Determination of VCD acute exposure effect on the GSTM:ASK1 protein complex in F344
rat ovaries
To determine if acute VCD exposure could cause dissociation of the GSTM:ASK1 protein
complex, ovaries were exposed to VCD for 2d and ovaries collected 6d after the onset of
culture. There was no effect of VCD exposure on the amount of GSTM protein bound to
ASK1 (Figure 6A, B). Also, no impact on the amount of GSTM in the unbound protein
fraction was observed (Figure 6C, D).
Bhattacharya et al. Page 6













Effect of PI3K inhibition on ovarian GSTM protein level
An increase in Gstm mRNA was previously demonstrated after 2d and 4d of PI3K inhibition
(Bhattacharya and Keating, 2012). In order to investigate whether altered Gstm mRNA was
correlated with GSTM protein after PI3K inhibition, LY294002 treated ovaries were
collected on 4d and 6d. Inhibition of PI3K increased (P < 0.05) GSTM protein levels by
40% and 71% on d4 and d6, respectively (Figure 7A, B).
Effect of PI3K inhibition on ovarian Ask1 mRNA level
Any impact of PI3K inhibition on Ask1 mRNA expression was determined in ovaries that
had been treated for 6d with LY294002. There was no effect of LY294002 treatment on
Ask1 mRNA, relative to control treated ovaries (Figure 8).
Discussion
Ovarian GSTP is increased in response to VCD exposure and inhibits JNK activity through
a protein:protein interaction, potentially contributing to the ovarian xenobiotic protective
response (Keating et al., 2010). In the PND4 mouse ovary, it has been shown that VCD (30
μM) exposure increases Gstm mRNA expression prior to observed VCD-induced follicle
loss (Keating et al., 2008). However, further investigation into a functional role for GSTM
during VCD-induced ovotoxicity has been lacking. Therefore, this study investigated the
ovarian response of Gstm to VCD exposure in cultured PND4 rat ovaries. Although there
was no change at the mRNA level at any time point studied, GSTM protein level was
increased at both 6d and 8d, and was highest at the time point at which follicle loss is first
observed (d6). These results support an involvement of GSTM in the ovarian protective
response to VCD exposure in rats.
Several studies have reported that GSTM inhibits the action of pro-apoptotic ASK1 (Cho et
al., 2001; Dorion et al., 2002). This negative regulation of ASK1 by GSTM is through
formation of an ASK1:GSTM protein complex. The complex is disrupted following external
environmental stress stimulus such as heat shock (Dorion et al., 2002). Such stress releases
GSTM from ASK1, and the unbound ASK1 initiates the c-JUN and p38 MAPK signaling
pathways in favor of apoptosis (Dorion et al., 2002; Ichijo et al., 1997). Thus, ASK1 is
involved in activating apoptotic signaling pathways.
It is known that VCD-induced primordial and small primary follicle loss is via apoptosis
(Hu et al., 2001; Devine et al., 2002; Springer et al., 1996a). Moreover, VCD-induced
apoptosis involves activation of JNK resulting in phosphorylation of c-JUN in small pre-
antral follicles which are the selective target of VCD (Hooser et al., 1994; Hu et al., 2002).
Because ASK1 activates JNK signaling, a role for ASK1 during VCD-induced ovotoxicity
was hypothesized. Additionally, GSTM is increased in response to VCD exposure, and can
form a complex with ASK1 in extra-ovarian tissues as an anti-apoptotic mechanism. Thus, it
was logical to investigate whether this was part of an ovarian protective response to VCD
exposure. Our data demonstrates induction of Ask1 mRNA at the time of VCD-induced
follicle depletion, thus supporting pro-apoptotic Ask1 involvement during VCD-induced
ovotoxicity. It was further shown that ovarian GSTM protein is bound to ASK1 and that this
complex is increased in response to VCD exposure at the time of follicle loss. This is similar
to the response of a GSTP:JNK complex during both VCD (Keating et al., 2010) and
DMBA exposures (Bhattacharya and Keating, 2012). There was no disruption of the
GSTM:ASK1 protein complex by VCD in terms of changes in the unbound form of GSTM.
Since the ovaries were exposed to VCD every alternate day, we surmised that this chronic
exposure may be the reason for lack of a clear disruption in the protein complex, since
GSTM may be continuously activated, and thus constantly binding ASK1. For this reason an
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experiment was performed to determine if a single acute VCD exposure would unveil more
radical changes in the GSTM:ASK1 complex. GSTM protein was confirmed to increase in
this paradigm, albeit marginally, however no major impact on GSTM:ASK1 protein binding
was observed. It may however be the case that more distinct changes may have taken place
immediately after VCD exposure (d2 or d4). Collectively, from both the chronic and acute
VCD exposures, it is evident that GSTM binds pro-apoptotic ASK1. GSTM-induced
inactivation of ASK1 may also lead to reduced JNK activity as was evident during VCD-
exposure (Keating et al., 2010) since ASK1 is an upstream regulator of JNK (Tobiume et al.,
2001). Therefore, it is hypothesized that the complexing of GSTM with ASK1 is part of an
ovarian protective response to VCD. That is, in response to VCD-induced apoptosis, GSTM
may be involved in an effort to prevent toxicity through binding and suppressing pro-
apoptotic action of ASK1 in cultured rat ovaries. Whether GSTM plays an additional role in
GSH conjugation cannot be confirmed by these studies.
Inhibition of PI3K prevents VCD-induced primordial follicle loss (Keating et al., 2009) and
VCD has been shown to inhibit phosphorylation of the PI3K members c-KIT, pAKT and to
decrease total FOXO3 protein (Keating et al., 2011). Inhibition of PI3K signaling increases
both mEH (Bhattacharya et al., 2012) and Gstp mRNA and protein expression (Bhattacharya
and Keating, 2012), indicating that this pathway regulates ovarian xenobiotic metabolism
gene expression. Also, inhibition of PI3K increases Gstm mRNA levels in the rat ovary
(Bhattacharya and Keating, 2012). Because a role for GSTM in VCD-induced toxicity was
supported by the data herein, an investigation of a regulatory role for PI3K in GSTM
translation was made. GSTM protein was increased by PI3K inhibition on d4 and d6 of
culture. Although we did not observe any impact of PI3K inhibition on Ask1 mRNA
induction, it is possible that increased GSTM binding to ASK1 could result during PI3K
inhibition however, this study cannot confirm that this is the case. Thus, these data further
add to an understanding of the involvement of PI3K in xenobiotic biotransformation enzyme
regulation (Bhattacharya et al., 2012; Bhattacharya and Keating et al., 2012). Gstm mRNA
was increased in mouse ovaries exposed to VCD, while protein levels were not affected
(Keating et al., 2008), thus there appears to be some species-specific differences in Gstm
regulation. Whether this regulation is through control of Gstm transcription or translation
remains to be determined, but could potentially involve the action of microRNA’s, as is the
case for Gstp (Zhang et al., 2012; Patron et al., 2012).
VCD exposure decreases PI3K signaling (Keating et al., 2011) and it is hypothesized that
this leads to impaired follicle viability, and accelerate activation of primordial follicles into
the growing follicular pool, both of which would lead to premature ovarian failure (Keating
et al., 2009). During the same time frame VCD also increases ovarian expression of mEH
(Bhattacharya et al., 2012), Gstp (Keating et al., 2010) and Gstm, likely as a result of PI3K
inhibition (summarized in Figure 9). PI3K regulates ovarian arylhydrocarbon receptor (Ahr)
and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) mRNA and protein expression
(Bhattacharya et al., 2012), both transcription factors that regulate xenobiotic metabolism
genes, including Gstm, thus they may be involved in VCD-induced Gstm activation. Why
the increased expression of the xenobiotic metabolism enzymes is insufficient to protect
against VCD-induced follicular destruction remains unclear, but may result either because
the enzymes are overwhelmed by continuous VCD exposure, or because VCD-induced
impairment of oocyte viability becomes impossible to counteract.
In summary, GSTM appears to be involved in the ovarian response to VCD; potentially
contributing to both VCD detoxification and prevention of apoptosis. Future studies are
aimed at further characterizing Gstm involvement during VCD-induced ovotoxicity.
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GSTM protein increases in response to ovarian VCD exposure
VCD increases Ask1 mRNA at the onset of follicle loss
Ovarian GSTM binds more ASK1 protein during VCD-induced ovotoxicity
PI3K regulates ovarian GSTM protein
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Figure 1. Temporal effect of chronic VCD exposure on Gstm mRNA expression
F344 PND4 rat ovaries were cultured in control (CT) media or media containing 30 μM
VCD for 2–8 d. Following incubation, total RNA was isolated, reverse transcribed to cDNA
and analyzed for Gstm and Actb mRNA expression by RT-PCR as described in materials
and methods. Values are expressed as fold-change relative to control ± SE; n=3 (10 ovaries
per pool).
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Figure 2. Temporal effect of chronic VCD exposure on GSTM protein level
F344 PND4 rat ovaries were cultured in control (CT) media or media containing 30 μM
VCD for 4–8 d. Following incubation, total protein was isolated and Western blotting was
performed to detect GSTM protein as described in materials and methods. (A)
Representative GSTM Western blot on d6. (B) Quantification of GSTM protein levels on
d4, d6, d8; Values are expressed as a percentage of control; n=3 (10 ovaries per pool). * P <
0.05; different from control.
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Figure 3. Effect of chronic VCD exposure on Ask1 mRNA expression
F344 PND4 rat ovaries were cultured with control (CT) media or media containing 30 μM
VCD for 6d. Following incubation, total RNA was isolated, reverse transcribed to cDNA
and analyzed for Ask1 mRNA expression by RT-PCR as described in materials and
methods. Values are expressed as fold-change relative to control ± SE; n=3 (10 ovaries per
pool). * P < 0.05; different from control.
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Figure 4. Effect of chronic VCD exposure on the GSTM:ASK1 protein complex
Ovaries from F344 PND4 rats were cultured in control media (CT) or media containing
VCD (30 μM) for 4 or 6 d. Ovaries were exposed to VCD on alternate days from the
beginning of culture. Following incubation, total protein was isolated and
immunoprecipitation was carried out as described in materials and methods. (A) ASK1
immunoprecipitation followed by detection of GSTM protein on d4 or d6; control = c, VCD
= v. (B) Quantification of the amount of GSTM protein bound to ASK1. (C) Representative
Western blot for unbound GSTM protein on d6. (D) Quantification of the amount of
unbound GSTM protein levels on d4 and d6. Values are expressed as a percentage of
control; n=3 (20 ovaries per pool). * P < 0.05; different from control.
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Figure 5. Effect of acute VCD exposure on GSTM protein level
Ovaries from F344 PND4 rats were cultured in control (CT) media or media containing
VCD (30 μM) for 6d with exposure to VCD at the onset of culture for 2d. Following
incubation, total protein was isolated and Western blotting was performed to detect GSTM
protein as described in materials and methods. (A) Representative Western blot on d6;
control = c, VCD = v. (B) Quantification of GSTM protein levels, values are expressed as a
percentage of control; n=3 (10 ovaries per pool). * P < 0.05; different from control.
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Figure 6. Effect of acute VCD exposure on GSTM:ASK1 protein complex formation
Ovaries from F344 PND4 rats were cultured in control (CT) media or media containing
VCD (30 μM) for 6d with exposure to VCD at the onset of culture for 2d. Following
incubation, total protein was isolated and immunoprecipitation was carried out as described
in materials and methods. (A) ASK1 immunoprecipitation, followed by detection of GSTM
protein by Western blotting on d6; control = c, VCD = v. (B) Quantification of the amount
of GSTM protein bound to ASK1, values are expressed as a percentage of control; n=3 (10
ovaries per pool). * P < 0.05; different from control. (C) Western blotting was performed on
the unbound protein fraction to detect GSTM protein; control = c, VCD = v. (D)
Quantification of the amount of unbound GSTM protein levels, values are expressed as a
percentage of control; n=3 (20 ovaries per pool). *P < 0.05; different from control.
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Figure 7. Effect of PI3K inhibition on ovarian GSTM protein level
F344 PND4 rat ovaries were cultured in media containing control or LY294002 (20 μM) for
4d or 6d. Total protein was isolated and Western blotting was performed to detect GSTM
protein levels. (A) Representative Western blot on d6; control = c, LY294002 = LY. (B)
Quantification of Western blotting for GSTM protein, values are expressed as a percentage
of control; n=3 (20 ovaries per pool). * P < 0.05; different from control.
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Figure 8. Effect of PI3K inhibition on Ask1 mRNA expression
F344 PND4 rat ovaries were cultured with control (CT) media or media containing 20 μM
LY294002 for 6d. Following incubation, total RNA was isolated, reverse transcribed to
cDNA and analyzed for Ask1 mRNA expression by RT-PCR as described in materials and
methods. Values are expressed as fold-change relative to control ± SE; n=3 (10 ovaries per
pool).
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Figure 9. Proposed mechanistic model
VCD exposure inhibits PI3K signaling, leading to increased GSTM protein, resulting in
increased GSTM:ASK1 protein interaction.
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